AMIT VERMA, MD
Psychiatric at Fannin St, Houston, TX

License number
Texas K7635
Category
Neurology
Type
Clinical Neurophysiology
License number
Texas K7635
Category
Neurology
Type
Neurology
License number
Texas K7635
Category
Psychiatric
Type
Sleep Medicine
Address
Address
6560 Fannin St SUITE 802, Houston, TX 77030
Phone
(713) 441-3970
(713) 790-2270 (Fax)

Organization information

See more information about AMIT VERMA at bizstanding.com

Methodist Department-Neurology - Amit Verma MD

6560 Fannin St STE 802, Houston, TX 77030

Categories:
Neurology Physicians & Surgeons
Phone:
(713) 441-3970 (Phone)

Professional information

Amit J Verma Photo 1

Dr. Amit J Verma - MD (Doctor of Medicine)

Specialties:
Pediatric Cardiology
Age:
48
Certifications:
Pediatric Cardiology, 2010, Pediatrics, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Pediatric Heart Specialists
7777 Forest Ln STE C855, Dallas 75230
Cypress Fairbanks Medical Center
10655 Steepletop Dr, Houston 77065
Medical Center of Plano
3901 West 15Th St, Plano 75075
Medical City Dallas Hospital and Medical City Children’s Hospital
7777 Forest Lane Cir, Dallas 75230
Pediatric Heart Specialists
7777 Forest Ln STE C855, Dallas 75230
Cypress Fairbanks Medical Center
10655 Steepletop Dr, Houston 77065
Medical Center of Plano
3901 West 15Th St, Plano 75075
Medical City Dallas Hospital and Medical City Children’s Hospital
7777 Forest Lane Cir, Dallas 75230
Education:
Medical School
University of Nebraska College of Medicine
Graduated: 2003
University of Texas Southwestern Medical Center


Amit Verma Photo 2

Amit Verma - Houston, TX

Work:
Calance Corporation
Architect - Security
CALANCE SOFTWARE PVT. LTD. - Gurgaon, Haryana
MANAGER TECHNOLOGIES
IBM INDIA PVT LTD - Noida, Uttar Pradesh
SENIOR APPLICATION CONSULTANT
WIPRO TECHNOLOGIES - Hyderabad, Andhra Pradesh
SOFTWARE ENGINEERE
SDG SOFTWARE INDIA PVT. LTD - Noida, Uttar Pradesh
ASSOCIATE SOFTWARE ENGINEERE
NIIT LTD. INDIA - New Delhi, Delhi
SYSTEMS EXECUTIVE
FIT - India
Developer
Education:
Institute of Informatics and Management Sciences - Meerut, Uttar Pradesh
Masters in Computer Application in Computer Science
Meerut College Meerut - Meerut, Uttar Pradesh
B. Sc. in Physics, Chemistry, Maths
Skills:
Security Architect, IBM Tivoli Identity Manager, IBM Tivoli Access Manager for eBusiness, IBM Tivoli Access Manager for Enterprise Single Sign-On


Amit Verma Photo 3

Dr. Amit Verma, Houston TX - MD (Doctor of Medicine)

Specialties:
Clinical Neurophysiology, Sleep Medicine, Sleep Medicine Psychiatry & Neurology
Address:
Methodist Neurological Institute
6560 Fannin St STE 802, Houston 77030
(713) 441-3780 (Phone)
Methodist Neurological Institut
6560 Fannin St STE 802, Houston 77030
(713) 441-3780 (Phone)
Methodist Neurological Institute Neurology
6560 Fannin St STE 802, Houston 77030
(713) 441-3780 (Phone)
Certifications:
Clinical Neurophysiology, 1999, Neurology, 2008, Sleep Medicine, 2009
Awards:
Healthgrades Honor Roll
Languages:
English, Hindi
Hospitals:
Methodist Neurological Institute
6560 Fannin St STE 802, Houston 77030
Methodist Neurological Institut
6560 Fannin St STE 802, Houston 77030
Methodist Neurological Institute Neurology
6560 Fannin St STE 802, Houston 77030
The Methodist Hospital
6565 Fannin St, Houston 77030
Education:
Medical School
Gov Med College
Graduated: 1992
Baylor College Med
Westchester Co Med Center
Duke University Hospital
Graduated: 1999


Amit Verma Photo 4

Methods For Treating Cancer Targeting Transglutaminase

US Patent:
2008027, Nov 13, 2008
Filed:
Oct 5, 2007
Appl. No.:
11/867717
Inventors:
Kapil Mehta - Houston TX, US
Amit Verma - Houston TX, US
International Classification:
A61K 39/395, A61K 31/70, A61P 31/00
US Classification:
4241301, 514 44
Abstract:
A method for treating cancer comprising inhibiting transglutaminase activity is provided. Suitable cancer types for which the methods of the present disclosure can be used to treat include, but are not limited to, pancreatic, breast, and ovarian cancers and melanoma. The inhibition of transglutaminase activity may be performed by one or more techniques, including, but not limited to, downregulating transglutaminase expression, inhibiting TG2 translation, or blocking TG2 enzymatic activity, such as with a small molecule inhibitor or intracellular antibody (intrabody).